| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910977 | Lung Cancer | 2015 | 6 Pages |
Abstract
The top 10 questions cover a wide portfolio of research (including assessing the value of immunotherapy, individualised chemotherapy, second-line treatment and immediate chemotherapy, monitoring patients with pleural thickening, defining the management of ascites in peritoneal mesothelioma, and optimising follow-up strategy). This list is an invaluable resource, which should be used to inform the prioritisation and funding of future mesothelioma research.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
R.J. Stephens, C. Whiting, K. Cowan, James Lind Alliance Mesothelioma Priority Setting Partnership Steering Committee James Lind Alliance Mesothelioma Priority Setting Partnership Steering Committee,